{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:56:04Z","timestamp":1783655764933,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T00:00:00Z","timestamp":1470355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.vaccine.2016.08.015","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T22:55:05Z","timestamp":1470783305000},"page":"4690-4697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Distribution of Bexsero\u00ae Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation"],"prefix":"10.1016","volume":"34","author":[{"given":"Carina","family":"Brehony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene M.C.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cunney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Richard","family":"Moxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.J.","family":"Maiden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.08.015_b0005","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1017\/S0950268807008825","article-title":"The changing face of meningococcal disease in West Africa","volume":"135","author":"Greenwood","year":"2007","journal-title":"Epidemiol Infect"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2016.08.015_b0010","doi-asserted-by":"publisher","first-page":"B64","DOI":"10.1016\/j.vaccine.2009.04.061","article-title":"Meningococcal carriage and disease - population biology and evolution","volume":"27","author":"Caugant","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.015_b0015","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal a conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.08.015_b0020","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1179\/2047773214Y.0000000126","article-title":"Global practices of meningococcal vaccine use and impact on invasive disease","volume":"108","author":"Ali","year":"2014","journal-title":"Pathogens Global Health"},{"key":"10.1016\/j.vaccine.2016.08.015_b0025","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"2","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.08.015_b0030","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMra0906357","article-title":"Advances in the development of vaccines against Neisseria meningitidis","volume":"362","author":"Tan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.08.015_b0035","doi-asserted-by":"publisher","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.015_b0040","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.08.015_b0045","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jinf.2015.09.035","article-title":"The introduction of the meningococcal B (MenB) vaccine (Bexsero\u00ae) into the national infant immunisation programme\u2013new challenges for public health","volume":"71","author":"Ladhani","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.08.015_b0050","article-title":"A \u2018tailor made\u2019 vaccine trialled as part of public health response to group B meningococcal epidemic in New Zealand","volume":"7","author":"Holst","year":"2003","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.08.015_b0055","first-page":"306","article-title":"Comparison of meningococcal disease surveillance systems - United States, 2005\u20132008","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.08.015_b0060","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/INF.0b013e318241f824","article-title":"The impact of meningococcal polymerase chain reaction testing on laboratory confirmation of invasive meningococcal disease","volume":"31","author":"Drew","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.08.015_b0065","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jinf.2013.06.007","article-title":"Added value of PCR-testing for confirmation of invasive meningococcal disease in England","volume":"67","author":"Heinsbroek","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.08.015_b0070","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00301-16","article-title":"The population and functional genomics of the Neisseria revealed with gene-by-gene approaches","author":"Maiden","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.015_b0075","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.015_b0080","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/S1473-3099(15)00267-4","article-title":"Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study","volume":"15","author":"Hill","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.015_b0085","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2016.08.015_b0090","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.08.015_b0095","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2015.20.28.21188","article-title":"Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015","volume":"20","author":"Campbell","year":"2015","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2016.08.015_b0100","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2016.08.015_b0105","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.015_b0110","doi-asserted-by":"publisher","first-page":"e0158315","DOI":"10.1371\/journal.pone.0158315","article-title":"Temporal changes in BEXSERO\u00ae antigen sequence type associated with genetic lineages of Neisseria meningitidis over a 15-year period in Western Australia","volume":"11","author":"Mowlaboccus","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2016.08.015_b0115","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1099\/mic.0.027995-0","article-title":"Variation of the factor H-binding protein of Neisseria meningitidis","volume":"155","author":"Brehony","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2016.08.015_b0120","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3201\/eid1004.030247","article-title":"PorA variable regions of Neisseria meningitidis","volume":"10","author":"Russell","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.015_b0125","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1128\/CVI.00825-13","article-title":"Neisseria adhesin a variation and revised nomenclature scheme","volume":"21","author":"Bambini","year":"2014","journal-title":"Clin Vaccine Immunol: CVI"},{"key":"10.1016\/j.vaccine.2016.08.015_b0130","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev.micro.59.030804.121325","article-title":"Multilocus sequence typing of bacteria","volume":"60","author":"Maiden","year":"2006","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.015_b0135","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1128\/JCM.39.11.4190-4192.2001","article-title":"Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms","volume":"39","author":"Grundmann","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.015_b0140","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/JCM.26.11.2465-2466.1988","article-title":"Numerical index of discriminatory ability of typing systems: an application of Simpson\u2019s index of diversity","volume":"26","author":"Hunter","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.015_b0145","author":"Team RC","year":"2015"},{"key":"10.1016\/j.vaccine.2016.08.015_b0150","doi-asserted-by":"publisher","first-page":"e1004041","DOI":"10.1371\/journal.pcbi.1004041","article-title":"ClonalFrameML: efficient inference of recombination in whole bacterial genomes","volume":"11","author":"Didelot","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.vaccine.2016.08.015_b0155","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1073\/pnas.90.10.4384","article-title":"How clonal are bacteria?","volume":"90","author":"Maynard Smith","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.08.015_b0160","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/bioinformatics\/17.12.1230","article-title":"Sequence type analysis and recombinational tests (START)","volume":"17","author":"Jolley","year":"2001","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2016.08.015_b0165","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1046\/j.1420-9101.1994.7050535.x","article-title":"Analytical results concerning linkage disequilibrium in models with genetic transformation and conjugation","volume":"7","author":"Hudson","year":"1994","journal-title":"J Evol Biol"},{"key":"10.1016\/j.vaccine.2016.08.015_b0170","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1098\/rspb.2009.2033","article-title":"Long-term evolution of antigen repertoires among carried meningococci","author":"Buckee","year":"2010","journal-title":"Proc Royal Soc B: Biol Sci"},{"key":"10.1016\/j.vaccine.2016.08.015_b0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/genetics\/131.2.479","article-title":"Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data","volume":"131","author":"Excoffier","year":"1992","journal-title":"Genetics"},{"key":"10.1016\/j.vaccine.2016.08.015_b0180","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1755-0998.2010.02847.x","article-title":"ARLEQUIN (version 3.5): arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows","volume":"10","author":"Excoffier","year":"2010","journal-title":"Mol Ecol Resour"},{"key":"10.1016\/j.vaccine.2016.08.015_b0185","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0169-4758(99)01559-8","article-title":"Population structure of pathogens: the role of immune selection","volume":"15","author":"Gupta","year":"1999","journal-title":"Parasitol Today"},{"key":"10.1016\/j.vaccine.2016.08.015_b0190","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nm0496-437","article-title":"The maintenance of strain structure in populations of recombining infectious agents","volume":"2","author":"Gupta","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.08.015_b0195","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0966-842X(01)01986-2","article-title":"Exploring the evolution of diversity in pathogen populations","volume":"9","author":"Gupta","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.015_b0200","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.08.015_b0205","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0966-842X(00)88918-0","article-title":"Epidemic spread and antigenic variability of Neisseria meningitidis","volume":"3","author":"Achtman","year":"1995","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2016.08.015_b0210","series-title":"Poster presented at international pathogenic neisseria conference, 2004; Milwaukee, WN, USA","article-title":"Worldwide epidemiology of meningococcal disease: examining a global risk","author":"Muros-Le Rouzic","year":"2004"},{"key":"10.1016\/j.vaccine.2016.08.015_b0215","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1574-6976.2006.00060.x","article-title":"A surveillance network for meningococcal disease in Europe","volume":"31","author":"Trotter","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.08.015_b0220","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1574-6976.2006.00056.x","article-title":"Multilocus sequence typing for global surveillance of meningococcal disease","volume":"31","author":"Brehony","year":"2007","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.08.015_b0225","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1016\/j.vaccine.2015.04.015","article-title":"MATS: global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine","volume":"33","author":"Medini","year":"2015","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16306727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T15:46:51Z","timestamp":1657036011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16306727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":45,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0264410X16306727"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of Bexsero\u00ae Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}